- Nationally-renowned biochemist and microbial geneticist recruited to help boost basic science and translational research -

Robert Deschenes, PhD, will chair Molecular Medicine and hold the Fred Wright Endowed Chair in Cancer Biology at USF Health.
Tampa, FL (Nov. 17, 2008) -- Following a national search for a top-level researcher to lead its Department of Molecular Medicine, USF Health has recruited Robert Deschenes, PhD, the Joseph F. Heil Jr. Professor and Chair of the Department of Biochemistry at Medical College of Wisconsin to fill the position. Dr. Deschenes will also hold the Fred Wright Endowed Chair in Cancer Biology and an appointment as Associate Dean for the USF/Moffitt Research Partnership. He joins USF Health on Jan. 5, 2009.
The appointment of Dr. Deschenes is the latest in a series of strategic and high-caliber recruitments made by Stephen Klasko, MD, MBA, CEO for USF Health and Dean of the College of Medicine, to build a leading academic medical center committed to new discovery and innovation.
“The recruitment of Dr. Deschenes is a huge shot in the arm for research at USF. He brings to USF Health the leadership, skills and vision needed to build a nationally prominent basic and translational research program,” Dr. Klasko said. “He will be an excellent catalyst for promoting collaborations and synergies with Moffitt Cancer Center, the Byrd Alzheimer’s Institute and our other academic partners, while working to fully integrate the Molecular Medicine Department with our missions of research, education and clinical care.”
Dr. Deschenes is one of the country’s leading researchers in the genetic and biochemical mechanisms of cell growth regulation in yeast – a critical field in the development of drug therapies for cancer and other diseases. He is a strong advocate of interdisciplinary research and the use of model systems in medical research. His own work takes advantage of the model eukaryote yeast to understand signaling pathways related to cancer. The work has uncovered new targets for the rational design of new cancer chemotherapeutic agents.
“Because it combines the strengths of microbiology, immunology and biochemistry, the Department of Molecular Medicine is uniquely positioned to contribute to the understanding of diseases in areas as diverse as cancer, neurobiology, diabetes and infectious diseases,” Dr. Deschenes said.
“In the last five years, USF has done a remarkable job developing a strong core research infrastructure, which I plan to build upon to help create a stronger, more competitive basic and translational science program. My goal is to develop an integrated Department of Molecular Medicine and a highly collaborative research environment that goes from molecules to medicine.”
In the last several years, Dr. Klasko has begun transforming research at USF Health through several key initiatives. These accomplishments have included creating a new School of Basic Biomedical Sciences, recruiting more National Institutes of Health-funded investigators in various basic science and clinical departments, establishing state-of-the-art core facilities and several key signature research programs at the College of Medicine, and enhancing the quality of graduate programs.
“The leadership of USF Health continues to follow through on the vision to transform the culture of this institution by instilling excellence in all our core missions,” said Abdul Rao, MD, MA, DPhil, senior associate vice president for USF Health and vice dean for research and graduate studies for the College of Medicine. “It is this transformation that allowed us to recruit a scientist of such distinguished academic caliber as Dr. Deschenes.
"This is the most important event in recent years in redefining the future of basic and translational sciences at this medical school.”
Dr. Deschenes will recruit several new faculty members to the Department of Molecular Medicine over the next few years, including several neurobiologists who will work out of the Byrd Alzheimer’s Center & Research Institute at USF.
In his Associate Dean role, he will serve as the principal liaison between researchers at USF and Moffitt, developing new opportunities for team grants and joint training grants.
Dr. Deschenes will work with Said Sebti, PhD, leader of the Drug Discovery Program at Moffitt, to establish and co-direct a Structural Biology Consortium that will include faculty and resources from Molecular Medicine, Moffitt and the Florida Center of Excellence for Biomolecular Identification and Targeted Therapeutics. In addition, he will oversee the creation of a High-Throughput Protein Production facility for determining protein structure and function.
Dr. Deschenes is currently the Chair of Biochemistry and the Joseph F. Heil Jr. Professor of Molecular Oncogenesis at Medical College of Wisconsin in Milwaukee, WI, where he also directs research for the college’s cancer center. A NIH-funded principal investigator, he studies eukaryotic signal transduction pathways involved in cancer and cell stress.
Dr. Deschenes received a master’s of science degree in Biochemistry from Tufts University, and his doctorate degree in Biochemistry from Purdue University. He conducted postdoctoral training in the Molecular Biology Department at Princeton University where he initiated studies on the post-translational regulation of Ras oncogene proteins in the model organism yeast, Saccharomyces cerevisiae. Before joining the Medical College of Wisconsin, Dr. Deschenes was vice chair of the Department of Biochemistry at the University of Iowa and director of the Genetics PhD program.
- USF Health -
USF Health is dedicated to creating a model of health care based on understanding the full spectrum of health. It includes the University of South Florida’s colleges of medicine, nursing, and public health; the schools of biomedical sciences as well as physical therapy & rehabilitation sciences; and the USF Physicians Group. With more than $360 million in research grants and contracts last year, USF is one of the nation’s top 63 public research universities and one of 39 community-engaged, four-year public universities designated by the Carnegie Foundation for the Advancement of Teaching. For more information, visit www.health.usf.edu.
- Photo by Eric Younghans/USF Health Communications